Primary Care-Based Injury Prevention Program Found to Reduce Pediatric Injuries in New Study
The program, when implemented with support of resident training and tangible tools, reduced parent-reported injuries throughout the first 2 years of life.
T2D Remission via Lifestyle Intervention Reduces CVD, CKD Risk: Daily Dose
Your daily dose of the clinical news you may have missed.
Nontraditional Risk Factors More Likely to Cause Stroke in Young Adults, Study Finds
Migraine was the most important nontraditional risk factor linked to stroke in adults aged 18 to 34 years and should be considered in evaluation for an event.
ARS Pharma Submits Response to FDA Complete Response Letter for neffy (epinephrine nasal spray)
Positive findings from a repeat dosing study of neffy under nasal allergen challenge conditions will support a potential PDUFA date of October 2, 2024, the company said.
FDA Clears First AI-Based Algorithm to Detect Heart Failure during Routine Exams
The Low EF AI is designed to detect low ejection fraction in 15 seconds during a primary care exam.
New Follow-Up Measure After Stool-Based CRC Test Could Improve Colonoscopy Rates, Outcomes
The quality performance measure is viable and reliable and could help improve early CRC detection rates via timely colonoscopy following abnormal stool-based test.
FDA Approves Fixed-Dose Macitentan/Tadalafil Tablets for PAH: Daily Dose
Atogepant Found More Effective for Migraine Prevention vs Rimegepant in New Analysis
Atogepant was associated with fewer monthly migraine days, fewer acute medication use days, and greater QoL compared with rimegepant after 12 weeks.
Vaping Associated with Increased Risk of Heart Failure, According to New Research
ACC.24: Data showed that individuals who used e-cigarettes were approximately 19% more likely to develop heart failure compared with those who had never vaped.
Obesity Care Needs More Cardiology Support, Suggest 2 New Studies
ACC.2024: Two abstracts presented during the ACC Scientific Sessions indicate cardiologists are very hesitant to prescribe medical therapy for obesity.
Sustained LDL-C Control in High-Risk Group via Remote Lipid Program: Daily Dose
CAC Progression in Postmenopausal Women Found Double that of Men in New Research
ACC.24: Loss of estrogen's cardioprotective effect could account for the 2-fold greater increase in CAC score seen among postmenopausal women compared with men.
Vaccination of Older Adults Against RSV Could Reduce Symptomatic Cases by 1 Million per Year: Modeling Study
The study looked at the impact over 3 years but found that most of the averted burden, including more than 8000 fewer deaths, occur in the first year after vaccination.
Young Adults Prescribed ADHD Stimulants May Face Higher Risk of Cardiomyopathy
ACC.24: Data showed that participants with ADHD who were prescribed stimulants were 17% more likely to develop cardiomyopathy at 1 year.
Erenumab Rx Early in Episodic Migraine Found Superior to Oral Prophylactic Agents for Efficacy, Tolerability, Adherence
The phase 4 APPRAISE trial found greater efficacy with erenumab after failure with 1 or 2 other preventives vs ongoing treatment with the nonspecific oral agents.
Disparities in Coronary Artery Calcium Screening: Daily Dose
Icosapent Ethyl Reduces MACE Across Range of Baseline Lp(a): REDUCE-IT Analysis
ACC.24: Icosapent ethyl was associated with reduced rate of MACE at all baseline levels of Lp(a) in participants with elevated TG and at high risk for CVD.
FDA Approves Aprocitentan for Treatment-Resistant HTN: Daily Dose
FDA Issues Warning Letters to 6 Companies Marketing Misbranded OTC Topical Analgesics
Specifically, the topical analgesics, available over the counter, may contain higher than labeled concentrations of lidocaine, according to the agency.
FDA Approves Vadadustat for Treatment of Anemia due to CKD in Patients on Dialysis
The FDA approved the oral medication to treat anemia in adult patients with chronic kidney disease on dialysis for at least 3 months.
